Results 61 to 70 of about 31,642 (216)

Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations

open access: yesPatient, 2018
ObjectiveAcute intermittent porphyria is a rare metabolic disorder that affects heme synthesis. Patients with acute intermittent porphyria may experience acute debilitating neurovisceral attacks that require frequent hospitalizations and negatively ...
A. Simon   +10 more
semanticscholar   +1 more source

The diagnosis and management of porphyria cutanea tarda (PCT)

open access: yesSouth African Family Practice, 2009
The porphyrias are a group of disorders in which excessive quantities of porphyrins or their precursors are produced. They are due to abnormalities in the control of the porphyrin-haem metabolic pathway.
Mojakgomo H. Motswaledi
doaj   +1 more source

Psychiatric Disorder in Porphyria: A Case Series

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth
Porphyria is a group of rare genetic disorders that affect the heme production pathway due to specific enzyme abnormalities. These conditions present diverse clinical symptoms, including gastrointestinal, neurovisceral, cutaneous, neurological, and ...
Poulomi Ghosh   +3 more
doaj   +1 more source

Medical and financial burden of acute intermittent porphyria

open access: yesJournal of Inherited Metabolic Disease, 2018
IntroductionA small proportion of patients with acute intermittent porphyria (AIP) suffer from recurrent porphyric attacks, with a severely diminished quality of life.
Rochus Neeleman   +6 more
semanticscholar   +1 more source

Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From a Placebo‐Controlled Clinical Trial

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 6, December 2025.
ABSTRACT Gamma‐hydroxybutyric acid (GHB), a potential agent in drug‐facilitated sexual assault, is difficult to detect due to rapid elimination, endogenous presence, and possible postsampling formation. We conducted a randomised, placebo‐controlled trial in 30 healthy volunteers, administering 50‐mg/kg sodium oxybate or placebo, to investigate symptoms,
Kathrine Bohn Faldborg   +3 more
wiley   +1 more source

Skin Fragility and Hyperpigmentation in a Patient With HIV

open access: yes
JEADV Clinical Practice, EarlyView.
Catalina Retamal   +2 more
wiley   +1 more source

Acute intermittent porphyria exacerbation following in vitro fertilization treatment

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Objectives: Assisted reproductive technology is commonly used for women with infertility. We report a case of acute intermittent porphyria associated with in vitro fertilization treatment.
Geok Huey New   +2 more
doaj   +1 more source

The Efficacy and Safety of Synchronous Parallel Ultrasound for the Clinical Improvement of Cellulite Using High‐Density Handpiece

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 12, December 2025.
ABSTRACT Background Cellulite is a common aesthetic condition of the skin, predominantly affecting more than 90% of postpubertal females. Energy‐based devices (EBDs) have demonstrated efficacy in treating a variety of dermatologic concerns. A controlled thermal injury to the dermis can stimulate remodeling of the extracellular matrix (ECM), leading to ...
Michael H. Gold   +6 more
wiley   +1 more source

Porphyria and kidney diseases

open access: yesClinical Kidney Journal, 2018
The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology.
N. Pallet   +5 more
semanticscholar   +1 more source

Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma

open access: yesCancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Background Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer‐related deaths worldwide. Despite advancements in antiviral therapies for hepatitis B (HBV) and hepatitis C (HCV), HCC incidence continues to rise due to metabolic dysfunction‐associated steatotic liver disease (MASLD), obesity ...
Muhammad Masroor Hussain   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy